Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain-Reference-Cited by-同舟云学术

Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain

Published:2018-07-13 Issue:11 Volume:35 Page:1605-1612
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:Diabet. Med.

Author:

Gomez-Peralta F.¹^ORCID,Lecube A.²,Fernández-Mariño A.³,Alonso Troncoso I.⁴,Morales C.⁵,Morales-Pérez F. M.⁶,Guler I.⁷,Cadarso-Suárez C.⁷

Affiliation:

1. Endocrinology and Nutrition Unit; Segovia General Hospital; Segovia

2. Endocrinology and Nutrition Unit; University Hospital Arnau de Vilanova; Institut de Recerca Biomèdica de Lleida and CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas, ISCIII); University of Lleida; Lleida

3. Endocrinology Unit; Complejo Hospitalario Hospital Xeral de Vigo; Vigo

4. Endocrinology Unit; Hospital Montecelo de Pontevedra; Pontevedra

5. Endocrinology and Nutrition Unit; Virgen Macarena Hospital; Seville

6. Endocrinology Unit; Hospital Universitario Infanta Cristina; Badajoz

7. Centre for Research in Molecular Medicine and Chronic Diseases (CiMUS); University of Santiago de Compostela; A Coruña Spain

Funder

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dme.13769/fullpdf

Reference29 articles.

1. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018;American Diabetes Association;Diabetes Care,2018

2. Diagnosis and management of diabetes: synopsis of the 2016 American Diabetes Association standards of medical care in diabetes;Chamberlain;Ann Intern Med,2016

3. Liraglutide: a review of its use in the management of type 2 diabetes mellitus;Perry;Drugs,2011

4. Novel diabetes drugs and the cardiovascular specialist;Sattar;J Am Coll Cardiol,2017

5. 8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2018;American Diabetes Association;Diabetes Care,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05

2. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22

3. Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients;Metabolites;2022-11-16

4. Usefulness of circulating EPAC1 as biomarkers of therapeutic response to GLP-1 receptor agonists;Acta Diabetologica;2022-08-04

5. High-Dose Liraglutide and SGLT2 Inhibitor: A Promising Combination;Clinics and Practice;2021-12-21